335 related articles for article (PubMed ID: 27634557)
1. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
Kitai T; Grodin JL; Mentz RJ; Hernandez AF; Butler J; Metra M; McMurray JJ; Armstrong PW; Starling RC; O'Connor CM; Swedberg K; Tang WH
Eur J Heart Fail; 2017 Feb; 19(2):241-249. PubMed ID: 27634557
[TBL] [Abstract][Full Text] [Related]
2. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
Takahama H; Yokoyama H; Kada A; Sekiguchi K; Fujino M; Funada A; Amaki M; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
J Cardiol; 2013 Jan; 61(1):58-64. PubMed ID: 23165149
[TBL] [Abstract][Full Text] [Related]
3. β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Feb; 8(4):e011121. PubMed ID: 30755071
[TBL] [Abstract][Full Text] [Related]
4. [Heart rate and outcome in patients with acute and chronic heart failure].
Oliva F; Ammirati E; Campana C; Carubelli V; Cirò A; Di Tano G; Mortara A; Senni M; Morandi F; Metra M
G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 1):3S-16. PubMed ID: 27030005
[TBL] [Abstract][Full Text] [Related]
5. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
Katz A; Maor E; Leor J; Klempfner R
Int J Cardiol; 2016 Oct; 221():198-204. PubMed ID: 27404675
[TBL] [Abstract][Full Text] [Related]
6. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2008 Jul; 52(3):190-9. PubMed ID: 18617067
[TBL] [Abstract][Full Text] [Related]
7. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial.
Toma M; Ezekowitz JA; Bakal JA; O'Connor CM; Hernandez AF; Sardar MR; Zolty R; Massie BM; Swedberg K; Armstrong PW; Starling RC
Eur J Heart Fail; 2014 Mar; 16(3):334-41. PubMed ID: 24464687
[TBL] [Abstract][Full Text] [Related]
8. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
9. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
[TBL] [Abstract][Full Text] [Related]
10. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
[TBL] [Abstract][Full Text] [Related]
11. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
[TBL] [Abstract][Full Text] [Related]
12. Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival.
Tsuchihashi-Makaya M; Kinugawa S; Yokoshiki H; Hamaguchi S; Yokota T; Goto D; Goto K; Takeshita A; Tsutsui H;
Circ J; 2010 Jul; 74(7):1364-71. PubMed ID: 20501958
[TBL] [Abstract][Full Text] [Related]
13. Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.
Dobre D; Zannad F; Keteyian SJ; Stevens SR; Rossignol P; Kitzman DW; Landzberg J; Howlett J; Kraus WE; Ellis SJ
Eur Heart J; 2013 Aug; 34(29):2271-80. PubMed ID: 23315907
[TBL] [Abstract][Full Text] [Related]
14. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
Kao DP; Davis G; Aleong R; O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Murphy GA; Sauer W; Bristow MR
Eur J Heart Fail; 2013 Mar; 15(3):324-33. PubMed ID: 23223178
[TBL] [Abstract][Full Text] [Related]
15. Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program.
Lopatin YM; Cowie MR; Grebennikova AA; Sisakian HS; Pagava ZM; Hayrapetyan HG; Abdullaev TA; Voronkov LG; Chesnikova AI; Tseluyko VI; Tarlovskaya EI; Dadashova GM; Berkinbaev SF; Glezer MG; Koziolova NA; Rakisheva AG; Kipiani ZV; Kurlyanskaya AK
Int J Cardiol; 2018 Jun; 260():113-117. PubMed ID: 29622423
[TBL] [Abstract][Full Text] [Related]
16. Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.
Ibrahim NE; Gaggin HK; Turchin A; Patel HK; Song Y; Trebnick A; Doros G; Maya JF; Cannon CP; Januzzi JL
Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):3-11. PubMed ID: 29490032
[TBL] [Abstract][Full Text] [Related]
17. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
